W Communication Agency - MORE ON-TIME WITH APO-GO® APO-go PEN CAMPAIGN When Grünenthal launched APO-go pen, a treatment of Parkinson's disease, they needed urgent help – a complete product launch package adapted
![SciELO - Brasil - Apomorphine in the treatment of Parkinson's disease: a review Apomorphine in the treatment of Parkinson's disease: a review SciELO - Brasil - Apomorphine in the treatment of Parkinson's disease: a review Apomorphine in the treatment of Parkinson's disease: a review](https://minio.scielo.br/documentstore/1678-4227/Zfkx8CbQRHcTszzF39DvGYP/278ad3b24be1a654f9e3fe7ed9f1600b07ce2c46.jpg)
SciELO - Brasil - Apomorphine in the treatment of Parkinson's disease: a review Apomorphine in the treatment of Parkinson's disease: a review
![Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management](https://www.futuremedicine.com/cms/10.2217/nmt.14.17/asset/images/medium/figure1.gif)
Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management
![Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management](https://www.futuremedicine.com/cms/10.2217/nmt.14.17/asset/images/medium/figure2.gif)